Skip to main content

Table 1 Demographics of subjects in the study

From: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis

Demographic

N = 20

Age (years)

 Mean (SD)

41.15 (9.29)

 (Range)

(24–55)

Gender

 Male

40% (8/20)

 Female

60% (12/20)

Diagnosis

 Relapsing remitting MS

75% (15/20)

 Primary progressive MS

20% (4/20)

 Secondary progressive MS

5% (1/20)

Disease duration (years)

 Mean = 7.7

  < 3

25% (5/20)

  4–6

25% (5/20)

  7–9

30% (6/20)

  10–12

10% (2/20)

  16–18

5% (1/20)

  19–21

5% (1/20)

Ambulation status

 Wheelchair

55% (11/20)

 Walker

20% (4/20)

 Bilateral cane

5% (1/20)

 Unilateral cane

20% (4/20)

 No assistance

45% (9/20)

Origin

 White/Caucasian

65% (13/20)

 African Descent

10% (2/20)

 Middle Eastern

5% (1/20)

 Other (1 each Hispanic, Brazilian, Panamanian, and multiracial: Hispanic/White/Native American)

20% (4/20)